Certis Oncology Solutions, a precision oncology and translational science company, showcased today its latest advancements in AI/ML at the Precision World Medicine Conference in Santa Clara, ...

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues in the human body. Now researchers have developed a method to detect ...

“Communities benefit from having students who are from the communities that we serve, helping us build trusting relationships ...

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes.

TheraSyn Bio and Rubix LS have announced a groundbreaking joint venture, Project Panacea, to develop a topical breast cancer therapy. Combining synthetic biology and AI-driven patient insights, the ...